TY - JOUR
T1 - Erratum
T2 - Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: Interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan (Arthritis Research and Therapy (2020) 22 (47) DOI: 10.1186/s13075-020-2125-2)
AU - Takeuchi, Tsutomu
AU - Tanaka, Yoshiya
AU - Tanaka, Sakae
AU - Kawakami, Atsushi
AU - Song, Yeong Wook
AU - Chen, Yi Hsing
AU - Rokuda, Mitsuhiro
AU - Izutsu, Hiroyuki
AU - Ushijima, Satoshi
AU - Kaneko, Yuichiro
AU - Nakashima, Yoshihiro
AU - Shiomi, Teruaki
AU - Yamada, Emi
N1 - Publisher Copyright:
© 2020 The Author(s).
PY - 2020/6/23
Y1 - 2020/6/23
N2 - Following publication of the original article [1], the authors identified an error in the 95% CI bars plotted on the graphs of Fig. 6a, b, and c. The CI numbers in the table below the graph are correct, but the upper and lower limit bars plotted on the graph are incorrect. The corrected Fig. 6 is given below.
AB - Following publication of the original article [1], the authors identified an error in the 95% CI bars plotted on the graphs of Fig. 6a, b, and c. The CI numbers in the table below the graph are correct, but the upper and lower limit bars plotted on the graph are incorrect. The corrected Fig. 6 is given below.
UR - http://www.scopus.com/inward/record.url?scp=85087003304&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087003304&partnerID=8YFLogxK
U2 - 10.1186/s13075-020-02247-3
DO - 10.1186/s13075-020-02247-3
M3 - Comment/debate
C2 - 32576246
AN - SCOPUS:85087003304
VL - 22
JO - Arthritis Research and Therapy
JF - Arthritis Research and Therapy
SN - 1478-6354
IS - 1
M1 - 155
ER -